Abstract
The article appearing in this issue of JAMA by Classen et al, 1 Computerized Surveillance of Adverse Drug Events in Hospital Patients, emphasizes the importance of adverse drug event (ADE) monitoring in hospitals. The authors' automated system includes rapid computerized identification of potential ADEs, with evaluation by a clinical pharmacist, and is coupled with enhanced hospital staff reporting. Over the 18-month study period, ADE detection and reporting increased 60-fold. The distinctive feature of this program is rapid communication with those providing the patient's medical care. The authors report that over 75% of verified ADEs in this study did not have the causative agent stopped until study personnel informed the physician of the ongoing ADE. 1 As recognized by the Food and Drug Administration (FDA), the Joint Commission on Accreditation of Healthcare Organizations, and others, 2-4 active hospital surveillance of drug use and resultant ADEs serves many purposes,
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
